Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇦🇺AU · Medicine#1765K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2.5K to 15K🎙 Weekly cadence·53 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
5K to 30K🇦🇺100% - Active Followers
Loyal subscribers who consistently listen
1.5K to 9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Episode 55: “Smart” skin sprays, innovations in moisturizers and cleansers, and other “OTC” advances
May 21, 2026
Unknown duration
New Eczema Treatments for Kids: Updates from the 2026 AAD Meeting and More
Apr 16, 2026
28m 04s
Help your teen take charge of their eczema care—without turning it into a battle
Feb 19, 2026
26m 49s
Eating fat-rich foods and changing baby skincare: Insights for prevention from GPER-funded research
Jan 26, 2026
29m 56s
Will Removing Foods Help Your Child’s Eczema—or Make Things Worse?
Nov 5, 2025
22m 01s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/21/26 | ![]() Episode 55: “Smart” skin sprays, innovations in moisturizers and cleansers, and other “OTC” advances | In Part 2 of our conversation with Dr. Peter Lio, we take an in-depth look at non-prescription eczema strategies, focusing on over-the-counter (OTC) innovations, microbiome re-balancing treatments, and "green space" therapy. Tune in to learn more about the latest-latest in options you can access on your own, without a doctor's prescription.Links Japanese study on green space and eczema risk: https://pubmed.ncbi.nlm.nih.gov/41942830/Lemma Health OTC treatment comparison tool: https://lemmahealth.com/treatments/moisturizing-therapy-for-eczema | — | ||||||
| 4/16/26 | ![]() New Eczema Treatments for Kids: Updates from the 2026 AAD Meeting and More✨ | eczema treatmentspediatric dermatology+3 | Dr. Peter Lio | Global Parents for Eczema ResearchChicago Integrative Eczema Center+3 | — | eczematreatments+6 | — | 28m 04s | |
| 2/19/26 | ![]() Help your teen take charge of their eczema care—without turning it into a battle✨ | eczema careteen independence+3 | Dr. Miriam Santer | University of SouthamptonGlobal Parents for Eczema Research | — | eczemateenagers+5 | — | 26m 49s | |
| 1/26/26 | ![]() Eating fat-rich foods and changing baby skincare: Insights for prevention from GPER-funded research✨ | eczema preventiongut microbiome+3 | Dr. Carina VenterDr. Theodora Karagounis+2 | Global Parents for Eczema Research | — | eczemagut microbiome+5 | — | 29m 56s | |
| 11/5/25 | ![]() Will Removing Foods Help Your Child’s Eczema—or Make Things Worse?✨ | eczemafood allergies+4 | Dr. Matthew Ridd | University of BristolTIGER+4 | — | eczemafood triggers+6 | — | 22m 01s | |
| 10/15/25 | ![]() From Foe to Friend: Could common skin fungi be harnessed to heal the skin barrier?✨ | eczemaskin fungi+4 | Dr. Salome LeibundGut-Landmann | University of ZurichExeter+5 | — | eczemaskin fungi+5 | — | 19m 02s | |
| 8/28/25 | ![]() How to Choose & Use Products To Control Eczema: A Science-Backed Roadmap✨ | eczema treatmentskin care for kids+5 | Dr. Helen BroughDr. Amber Atwater | Children’s Allergy DoctorsGeorge Washington University+3 | — | eczemaskin care+5 | — | 38m 19s | |
| 5/22/25 | ![]() Staph’s secret superpower and their accomplice Streptococcus✨ | Staph bacteriaskin barrier+3 | Dr. Nathan ArcherDr. Laine Feller | John Hopkins School of MedicineSociety for Investigative Dermatology+1 | — | Staph bacteriaskin barrier+5 | — | 13m 46s | |
| 4/30/25 | ![]() New nonsteroidal eczema cream approved for kids✨ | eczema treatmentFDA approval+4 | Dr. Leon Kircik | TapinarofIcahn School of Medicine+4 | — | eczemaTapinarof+5 | — | 22m 23s | |
| 3/20/25 | ![]() Hot off the press - What researchers are talking about at AAAAI Allergy Conference.✨ | eczemaallergies+4 | Dr. Jessica Hui-BeckmanDr. Kirsi Jarvinen-Seppo | National Jewish HealthUniversity of Rochester | — | eczemamoisturizers+5 | — | 16m 50s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/19/25 | ![]() Could biologic injectables change the eczema trajectory?✨ | biologicseczema treatment+3 | Dr. Amy PallerDr. Elaine Siegfried | dupilumabNorthwestern University Chicago+1 | — | biologicseczema+5 | — | 21m 01s | |
| 11/13/24 | ![]() You are what you eat or, more precisely, what your MICROBIOME eats. | How much influence does the gut microbiome have on developing eczema or allergies? Turns out, quite a lot. Join this special excerpt from our research symposium to learn how antibiotics in pregnancy and early childhood increases eczema risk and how adding "biotics" might prevent it in the first place. Our speakers are Dr. David Margolis (University of Pennsylvania) and Dr. Nikole Kimes (Siolta Therapeutics). If you like our podcast, please consider supporting it with a tax deductible donation. | — | ||||||
| 10/22/24 | ![]() Can Traditional Chinese Medicine treat eczema? | Traditional Chinese Medicine (TCM) uses biological extracts to treat disease. Eczema sufferers may take a herbal bath, apply a specially formulated cream or drink herbal tea as part of TCM treatment. Dr. Xiu Min Li from New York Medical College explains TCM and we ask: Is Traditional Chinese Medicine (TCM) safe for newborns? Can you use TCM and topical steroids simultaneously? Could TCM prevent the allergic march? Research mentionedInvestigation of Berberine's Potential in Attenuating Staphylococcus aureus-Induced Inflammatory ResponsesInvestigation of In vitro Anti-inflammatory and Antimicrobial Effects of BerberineEffect of Traditional Chinese Medicine (TCM) in moderate-to-severe eczema in clinic and animal model: beyond corticosteroidsTraditional Chinese medicine for food allergy and eczemaEffect of traditional Chinese medicine on skin lesions and quality of life in patients with moderate to severe eczemaEfficacy and safety of Chinese herbal medicine for atopic dermatitis: Evidence from eight high-quality randomized placebo-controlled trials. | — | ||||||
| 9/14/24 | ![]() How to get smiles while applying moisturizer, sleep strategies and other eczema care advice | Are you feeling lost and don’t know where to find trusted advice on managing eczema? Introducing ECZHALE, your one-stop-shop for reliable information and resources on eczema care. Join Dr. Jennifer LeBovidge, psychologist and Assistant Professor at the Atopic Dermatitis Center at Boston Children’s Hospital, and GPER’s Christine Pham Cutaran as they discuss the challenges of being an eczema caregiver and where you can turn for help. Literature mentionedMultidisciplinary interventions in the management of atopic dermatitisAtopic dermatitis: therapeutic care delivery: therapeutic education, shared decision-making, and access to careImproving patient education for atopic dermatitisResourcesECZHALE wellness hubSupport for Eczema CaregiversTreatment Navigator | — | ||||||
| 7/24/24 | ![]() Could we take a pill to eradicate Staph aureus on the skin? | Is getting rid of Staph aureus in the gut the key to improving eczema? And can we control it without antibiotics? Join us as we ask these questions and more of Dr. Michael Otto, Chief of the Pathogen Molecular Genetics Section at the National Institute of Allergies and Infectious Diseases. (And if you like our podcast, consider supporting it with a tax deductible donation). Research mentionedProbiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: a phase 2, double-blind, randomised, placebo-controlled trialCommensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective ceramides The association between Staphylococcus aureus colonization on cheek skin at 2 months and subsequent atopic dermatitis in a prospective birth cohortSkin microbiota analysis-inspired development of novel anti-infectivesCombined antibiotic, steroid, and moisturizer for atopic dermatitis: A two‐year case series of patient‐reported outcomes | — | ||||||
| 6/27/24 | ![]() Who gets eczema and who grows out of it - and why? Are detergents, antibiotics and tiny plastics to blame? | Korey Capozza travels to Spain for the European Academy of Allergy and Clinical Immunology Congress where she speaks to researchers that are trying to explain the allergy epidemic and what we can do about it. Highlights: Dr. Magdalena Zemelka-Wiacek (Poland) explains microplastics cause inflammation. Tami Landau (Israel) uses “big data” to determine which children will develop eczema, and Dr Thomas Bieber (Germany) accesses the German Biobank to understand why some children go into remission. Research MentionedMechanisms of gut epithelial barrier impairment caused by food emulsifiers polysorbate 20 and polysorbate 80 Follow-up to adolescence after early peanut introduction for allergy prevention The potential impact of nano-and microplastics on human health: Understanding human health risksBiomarkers for phenotype-endotype relationship in atopic dermatitisDevelopment of a predictive model for pediatric atopic dermatitis | — | ||||||
| 5/29/24 | ![]() Pregnancy and the allergic trajectory | Could the diet and lifestyle of a mother during pregnancy influence whether her baby will develop eczema? Our podcast guests are studying the role that diet and the gut microbiome play in pregnancy. Join Dr. Carina Venter and Dr. Susan Lynch as we discuss what pregnant mothers can do to reduce the chances of baby developing eczema or allergies. (And if you like our podcast, consider supporting it with a tax deductible donation).Research mentionedDelayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementationHeritable vaginal bacteria influence immune tolerance and relate to early-life markers of allergic sensitization in infancyDifferent Measures of Diet Diversity During Infancy and the Association with Childhood Food Allergy in a UK Birth Cohort Study The Maternal Diet Index and Offspring Microbiota at 1 Month of Life: Insights from the Mediterranean Birth Cohort MAMI | — | ||||||
| 5/29/24 | ![]() New Eczema Guidelines from the Allergy Societies: Takeaways and Surprises | Frustrated by eczema care that ignores patient priorities? New guidelines from the medical societies for allergists and immunologists may help change that. These guidelines were informed by the views of eczema patients and caregivers and based in evidence (hallelujah!). We chat with the guideline co-authors Dr. Lynda Schneider, founder and director of the Atopic Dermatitis Center at Boston Children’s Hospital, and Dr. Derek Chu, director of the challenge clinic for allergy diagnosis, research and treatment at McMaster University, about some of the new and surprising ideas they recommend. (And if you like our podcast, consider supporting it with a tax deductible donation). Read the transcript.Research mentionedAtopic dermatitis guidelines: 2023 Is Food-Triggered Atopic Dermatitis a Form of Systemic Contact Dermatitis? | — | ||||||
| 3/21/24 | ![]() Research Highlights from the American Academy of Dermatology Meeting 2024 | Five GPER staff members attended the American Academy of Dermatology conference in February, the biggest gathering of dermatologists worldwide. We bring you the newest treatments and latest research straight from the source. Join our conversation with GPER staffers Korey Capozza, Kara Orevillo, Christine Cutaran and Michelle Tu about what stood out this year. (And if you like our podcast, consider supporting it with a tax deductible donation). | — | ||||||
| 2/13/24 | ![]() Is the gut microbiome the key to allergic disease? | Could we cure allergies by taking probiotics or transplanting the gut microbiome from a healthy person? What does all this mean for eczema/allergy prevention? To find out, join our conversation with Dr. Rima Rachid, allergist and immunologist at Harvard Children’s Hospital, and Meenal Lele, eczema mom and author of Baby and the Biome. We discuss the promising trials with fecal microbiota transplants for food allergic children as well as the best probiotic to take for eczema and when it’s important to take it. (And if you like our podcast, consider supporting it with a tax deductible donation). Literature featured in this podcastThe microbial origins of food allergyEvaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients Lactobacillus rhamnosus Used in the Perinatal Period for the Prevention of Atopic Dermatitis in InfantsThe Baby and the Biome book | — | ||||||
| 1/17/24 | ![]() Brilliant new ideas for beating eczema from eczema parents | The winners of the 2023 Big Ideas for Eczema contest share their novel ideas and how they came up with them. Our citizen scientist winners are Elizabeth Shores, Hannah Mitchell and Armando de la Libertad. Would you try these ideas? (If you like our podcast consider supporting it with a tax deductible donation.) If you have an idea of your own, find out more about the Big Ideas 2024 competition here. | — | ||||||
| 12/19/23 | ![]() Eczema Research Highlights of 2023 | What are the top research discoveries of 2023 related to eczema? Tune in to learn about new, needle-free Epi-Pen alternatives, painless tests for detecting eczema before it appears, and insights about how to address anxiety and depression related to eczema. Guests include Albert Chong of University of Southern California, Dr. Ruchi Gupta of Northwestern University, Dr. Ian Myles of NIH, and Dr. Kiwako Yamamoto-Hanada of National Children's Hospital, Tokyo. P.S. If you like our podcast, consider making a donation to GPER!Research discussed in this podcastmRNAs in skin surface lipids unveiled atopic dermatitis at 1 monthPatients' and Caregivers' Preferences for Mental Health Care and Support in Atopic Dermatitis Innovations in the treatment of anaphylaxis: A review of recent data - ScienceDirectPharmacokinetics and pharmacodynamics of epinephrine sublingual film versus intra-muscular epinephrine - Journal of Allergy and Clinical ImmunologyShotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis | — | ||||||
| 11/30/23 | ![]() What’s hot in eczema prevention? | Can moisturizers help prevent eczema? If so: when, what and how should they be applied? Can probiotics help? If so: who should take them - mother or baby? These questions and more are answered by Helen Brough, pediatric allergist and head of service at Evelina London Children's Hospital (UK). As part of our recent research symposium, she explains what research is going on in eczema management and prevention and what is still needed to make prevention a reality. She also has important tips for eczema care now. (If you like our podcast consider supporting it with a tax deductible donation.)Research discussed in this episodeEarly initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants—The STOP-AD randomised controlled trialSkin care interventions in infants for preventing eczema and food allergyProbiotic supplementation for prevention of atopic dermatitis in infants and children: a systematic review and meta-analysisEarly intervention and prevention of allergic diseasesEmollients in infancy to prevent atopic dermatitis: a systematic review and meta‐analysisEpicutaneous sensitization in the development of food allergy: what is the evidence and how can this be prevented? | — | ||||||
| 8/24/23 | ![]() The inflammation-microbiome connection and how new therapies can correct both | New biological therapies like dupilumab target Type 2 inflammation, but new research shows they are also modifying the skin microbiome. In this episode we discuss what Type 2 inflammation is, why it matter in eczema, and how it modifies the microbiome. Our guest is Dr. Lisa Beck (Co-Director of the Center for Allergic Disease Research, University of Rochester Medical Center, NY) who has dedicated her 35 year career to understanding why some eczema patients are susceptible to skin infections and finding safe and effective eczema treatments.Research associated with this podcastType 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic DermatitisTralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitisRapid Reduction in Staphylococcus aureus in Atopic Dermatitis Subjects Following Dupilumab Treatment | — | ||||||
| 7/27/23 | ![]() Is Dupixent forever? Is tapering Dupixent desirable or even possible? | Dupixent has transformed the lives of people with moderate to severe eczema, but will patients need to use it indefinitely? In this episode we explore tapering Dupixent (also known as dupilumab) with two researchers from University Medical Center Utrecht in the Netherlands that have created a patient-led roadmap for successful tapering. They are: Pediatric Dermatologist Dr. Marlies de Graaf, Head of the National Expertise Center of Atopic Dermatitis in Children; and Dr. Celeste Boesjes, who is a PhD candidate and Medical Doctor.Research Discussed in this PodcastSuccessful tapering of dupilumab in atopic dermatitis patients with low disease activity: a large pragmatic daily practice study from the BioDay registryAssociation of serum dupilumab levels at 16 weeks with treatment response and adverse effects in patients with atopic dermatitis: a prospective clinical cohort study from the BioDay registryPatient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitisDupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28‐week clinical and biomarker results from the BioDay registryDupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: a retrospective analysis | — | ||||||
Showing 25 of 55
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.

